GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » BioNote Inc (XKRX:377740) » Definitions » Enterprise Value

BioNote (XKRX:377740) Enterprise Value : ₩4,451 Mil (As of Jun. 08, 2024)


View and export this data going back to 2022. Start your Free Trial

What is BioNote Enterprise Value?

Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, BioNote's Enterprise Value is ₩4,451 Mil. BioNote's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-59,183 Mil. Therefore, BioNote's EV-to-EBIT ratio for today is -0.08.

EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, BioNote's Enterprise Value is ₩4,451 Mil. BioNote's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-50,891 Mil. Therefore, BioNote's EV-to-EBITDA ratio for today is -0.09.

EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, BioNote's Enterprise Value is ₩4,451 Mil. BioNote's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was ₩94,216 Mil. Therefore, BioNote's EV-to-Revenue ratio for today is 0.05.


BioNote Enterprise Value Historical Data

The historical data trend for BioNote's Enterprise Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNote Enterprise Value Chart

BioNote Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Enterprise Value
- - - 153,996.52 37,987.83

BioNote Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Enterprise Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -36,844.11 -164,387.86 74,093.35 37,987.83 17,718.35

Competitive Comparison of BioNote's Enterprise Value

For the Medical Devices subindustry, BioNote's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


BioNote's Enterprise Value Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BioNote's Enterprise Value distribution charts can be found below:

* The bar in red indicates where BioNote's Enterprise Value falls into.



BioNote Enterprise Value Calculation

Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.

BioNote's Enterprise Value for the fiscal year that ended in Dec. 2023 is calculated as

BioNote's Enterprise Value for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioNote  (XKRX:377740) Enterprise Value Explanation

When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.

If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.

The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.

For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.

Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.

1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.

BioNote's EV-to-EBIT for today is

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=4451.275/-59183.147
=-0.08

BioNote's current Enterprise Value is ₩4,451 Mil.
BioNote's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-59,183 Mil.

2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.

BioNote's EV-to-EBITDA for today is:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA(TTM)
=4451.275/-50890.926
=-0.09

BioNote's current Enterprise Value is ₩4,451 Mil.
BioNote's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-50,891 Mil.

3. EV-to-Revenue is calculated as Enterprise Value divided by its Revenue.

BioNote's EV-to-Revenue for today is:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=4451.275/94216.34
=0.05

BioNote's current Enterprise Value is ₩4,451 Mil.
BioNote's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩94,216 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


BioNote Enterprise Value Related Terms

Thank you for viewing the detailed overview of BioNote's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.


BioNote (XKRX:377740) Business Description

Traded in Other Exchanges
N/A
Address
22, Samsung 1-ro 4-gil, Gyeonggi-do, Hwaseong-si, KOR
BioNote Inc is a manufacturer of diagnostic kits and equipment for animal diseases and is equipped with a wide product portfolio, from initial screening tests to molecular diagnosis. Its animal diagnostics products comprise of Vcheck F, Vcheck M, Vcheck C, Rapid, and ELISA.

BioNote (XKRX:377740) Headlines

No Headlines